Wednesday, July 6, 2022
Home Biotech News 2022 Watch List Page 2

2022 Watch List

    Latest

    The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

    2022 Watch List Editor / Curator -
    The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma...

    Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.

    2022 Watch List Editor / Curator -
    Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Not wanting to be caught...
    12Page 2 of 2

    Latest article

    Smart for Life (SMFL) Capitulates?

    Client Editor / Curator -
    We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

    Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

    Biotech News Editor / Curator -
    Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

    Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

    Bitcoin Editor / Curator -
    Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: roland@institutionalanalyst.com
    © Managed by Revelers.IO Media Group Inc.